Schäfer A - Search Results

1

Rapid regulation of platelet activation in vivo by nitric oxide.

Schäfer A, Wiesmann F, Neubauer S, Eigenthaler M, Bauersachs J, Channon KM. Schäfer A, et al. Circulation. 2004 Apr 20;109(15):1819-22. doi: 10.1161/01.CIR.0000126837.88743.DD. Epub 2004 Apr 5. Circulation. 2004. PMID: 15066953

2

Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.

Mülsch A, Bauersachs J, Schäfer A, Stasch JP, Kast R, Busse R. Mülsch A, et al. Among authors: schafer a. Br J Pharmacol. 1997 Feb;120(4):681-9. doi: 10.1038/sj.bjp.0700982. Br J Pharmacol. 1997. PMID: 9051308 Free PMC article.

3

Isometric contraction induces the Ca2+-independent activation of the endothelial nitric oxide synthase.

Fleming I, Bauersachs J, Schäfer A, Scholz D, Aldershvile J, Busse R. Fleming I, et al. Among authors: schafer a. Proc Natl Acad Sci U S A. 1999 Feb 2;96(3):1123-8. doi: 10.1073/pnas.96.3.1123. Proc Natl Acad Sci U S A. 1999. PMID: 9927704 Free PMC article.

4

Angiotensin-converting enzyme inhibition and endothelin antagonism for endothelial dysfunction in heart failure: mono-or combination therapy.

Bauersachs J, Fraccarollo D, Schäfer A, Ertl G. Bauersachs J, et al. Among authors: schafer a. J Cardiovasc Pharmacol. 2002 Oct;40(4):594-600. doi: 10.1097/00005344-200210000-00013. J Cardiovasc Pharmacol. 2002. PMID: 12352322

5

Endothelium-dependent and -independent relaxation and VASP serines 157/239 phosphorylation by cyclic nucleotide-elevating vasodilators in rat aorta.

Schäfer A, Burkhardt M, Vollkommer T, Bauersachs J, Münzel T, Walter U, Smolenski A. Schäfer A, et al. Biochem Pharmacol. 2003 Feb 1;65(3):397-405. doi: 10.1016/s0006-2952(02)01523-x. Biochem Pharmacol. 2003. PMID: 12527332

6

High-altitude pulmonary edema: potential protection by red wine.

Schäfer A, Bauersachs J. Schäfer A, et al. Nutr Metab Cardiovasc Dis. 2002 Oct;12(5):306-10. Nutr Metab Cardiovasc Dis. 2002. PMID: 12616811 Review.

7

Inhibition of platelet activation in congestive heart failure by aldosterone receptor antagonism and ACE inhibition.

Schäfer A, Fraccarollo D, Hildemann S, Christ M, Eigenthaler M, Kobsar A, Walter U, Bauersachs J. Schäfer A, et al. Thromb Haemost. 2003 Jun;89(6):1024-30. Thromb Haemost. 2003. PMID: 12783115

8

Addition of the selective aldosterone receptor antagonist eplerenone to ACE inhibition in heart failure: effect on endothelial dysfunction.

Schäfer A, Fraccarollo D, Hildemann SK, Tas P, Ertl G, Bauersachs J. Schäfer A, et al. Cardiovasc Res. 2003 Jun 1;58(3):655-62. doi: 10.1016/s0008-6363(03)00333-x. Cardiovasc Res. 2003. PMID: 12798439

9

Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion.

Schäfer A, Schulz C, Eigenthaler M, Fraccarollo D, Kobsar A, Gawaz M, Ertl G, Walter U, Bauersachs J. Schäfer A, et al. Blood. 2004 Jan 15;103(2):407-12. doi: 10.1182/blood-2002-10-3260. Epub 2003 Sep 11. Blood. 2004. PMID: 12969973 Free article.

10

Endothelial dysfunction in congestive heart failure: ACE inhibition vs. angiotensin II antagonism.

Schäfer A, Fraccarollo D, Tas P, Schmidt I, Ertl G, Bauersachs J. Schäfer A, et al. Eur J Heart Fail. 2004 Mar 1;6(2):151-9. doi: 10.1016/j.ejheart.2003.10.009. Eur J Heart Fail. 2004. PMID: 14984722 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,749 results

Search Page

Filters